RJA
EXEL icon

Ross\Johnson & Associates’s Exelixis EXEL Stock Holding History

Ross\Johnson & Associates’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$163 Buy
+3
New +$146 ﹤0.01% 244
2025
Q2 		– Sell
-40
Closed -$1.48K – 254
2025
Q1 		$1.48K Buy
+40
New +$1.43K 0.03% 187

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ross\Johnson & Associates's EXEL Position: Q2 2026 in Review

Ross\Johnson & Associates opened a new position in Exelixis (EXEL) in Q2 2026: 3 shares worth $163. The stake represents ﹤0.01% of the portfolio and ranks #244 among its holdings. This is a return to the name: Ross\Johnson & Associates previously reported a position in EXEL as recently as Q1 2025.

Ross\Johnson & Associates first reported a position in EXEL in Q1 2025 and has held it in 2 quarters since. The position peaked at $1.48K in Q1 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Ross\Johnson & Associates held 3 shares of Exelixis worth $163 as of Q2 2026.
  • Exelixis was a new Ross\Johnson & Associates position in Q2 2026.
  • Exelixis made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #244 holding.
  • Ross\Johnson & Associates first reported a position in Exelixis in Q1 2025 and has held it in 2 quarters since.
  • Ross\Johnson & Associates's Exelixis position peaked at $1.48K in Q1 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.